Advances in Chitosan-Based Nanoparticles for Drug Delivery.

Int J Mol Sci · 2021 · PMC8431817 · PMID 34502560

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

extremely significantp < 0.001actually significant

The improved Cmax (668.24 ± 29.66 ng/mL) with AUC0–24 (11370.02 ± 191.05 min × ng/mL) was observed extremely significant ( p < 0.001) via i.n. as compared to oral (Cmax 208.76 ± 17.01 ng/mL, AUC0–24 2223.77 ± 42.08 min × ng/mL) and i.v.

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.